Clinical Trials Browser

Unknown × Carcinoma, Renal Cell × pembrolizumab × Clear all

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03280667 2023-03-29

KEYPAD

Phase 2 Unknown

59 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04913025 2022-09-21

REFINE

Phase 2 Unknown

160 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT04995016 2021-08-06

PANDORA

Phase 2 Unknown

18 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Phase 2 Unknown

40 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

KEYPAD

REFINE

PANDORA

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.